The Global Opioid Induced Constipation Market Size is Anticipated to Exceed USD 2.15 Billion by 2033, Growing at a CAGR of 4.76% from 2023 to 2033. Opioid-induced constipation is a frequent adverse event that is caused by receiving long-term therapy of opioids for chronic pain therapy. About 40-60% of patients receiving opioids are suffering from opioid-induced constipation.